Long-term outcomes from adding durvalumab to neoadjuvant treatment of operable gastroesophageal cancers: Results from a multicenter study LUD2015-005
Middleton, Mark R., Karydis, Ioannis, Lu, Xin, Ryan, Aileen, Venhaus, Ralph Rudolph, Ramirez, Kristen Auferio, Macri, Mary, Ricciardi, Toni, Lawrence, Megan, Scott-Brown, Martin, Griffiths, Gareth Owen, Collins, Linda, Griffiths, Lucinda, Wilding, Sam, Lord, Simon, Owen, Richard, Petty, Russell D.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC)
Gandhi, Leena, Aufiero Ramirez, Kristen, Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Study to evaluate intraperitoneal (IP) ONCOS-102 with systemic durvalumab in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Phase 2 results
Zamarin, Dmitriy, Odunsi, Kunle, Zsiros, Emese, Slomovitz, Brian M., Pimentel, Agustin, Duska, Linda R., Reilley, Matthew, Nemunaitis, John J., Hamouda, Danae M., Patel, Hitendra, Segal, Neil Howard, Pesci, Giulio, Holland, Aliya, Shohara, Lisa, Schwarzenberger, Paul Otto, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Jaderberg, Magnus Erik, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase I/II study to evaluate systemic durvalumab + intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results
Zamarin, Dmitriy, Odunsi, Kunle, Slomovitz, Brian M., Duska, Linda R., Nemunaitis, John J., Reilley, Matthew, Bykov, Yonina, Holland, Aliya, Hubbard-Lucey, Vanessa M., Shohara, Lisa, Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Jaderberg, Magnus Erik, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase 1/2 study of in situ vaccination with tremelimumab + intravenous (IV) durvalumab + poly-ICLC in patients with select relapsed, advanced cancers with measurable, biopsy-accessible tumors
Slingluff, Craig L., Dasilva, Daniel, Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph, Bhardwaj, Nina
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM)
Reardon, David A., Kaley, Thomas Joseph, Dietrich, Jorg, Clarke, Jennifer Leigh, Dunn, Gavin, Lim, Michael, Cloughesy, Timothy Francis, Gan, Hui Kong, Park, Andrew J., Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase 1 study to evaluate the safety and efficacy of immunotherapy with tremelimumab and durvalumab in multiple myeloma patients receiving high dose chemotherapy and autologous stem cell transplant (HDT/ASCT) + peripheral blood lymphocyte (PBL) reinfusion
Lesokhin, Alexander M., Chung, David J., Cho, Hearn J., Shohara, Lisa, Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1 study to evaluate safety and efficacy of ipilimumab + nivolumab + external beam radiotherapy in patients with metastatic melanoma
Postow, Michael Andrew, Knox, Susan Jane, McCabe, Danielle, Macri, Mary J., Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph Rudolph, Barker, Christopher Andrew
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
Postow, Michael A., Knox, Susan Jane, Goldman, Debra, Panageas, Katherine, Halpenny, Darragh, McCabe, Danielle, Macri, Mary J., Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph Rudolph, Barker, Christopher Andrew
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma
Slingluff, Craig L., Zarour, Hassane M., Postow, Michael A., Friedlander, Philip Adam, Devoe, Craig E., Smith, Kelly, Deacon, Donna, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 2 study to evaluate safety and efficacy of MEDI4736 (durvalumab [DUR]) in glioblastoma (GBM) patients: An update
Reardon, David A., Kaley, Thomas Joseph, Dietrich, Jorg, Clarke, Jennifer Leigh, Dunn, Gavin P, Lim, Michael, Cloughesy, Timothy Francis, Gan, Hui Kong, Park, Andrew J., Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, DUR) + tremelimumab (TRE) in patients with advanced solid tumors
Callahan, Margaret K., Odunsi, Kunle, Sznol, Mario, Nemunaitis, John J., Ott, Patrick Alexander, Dillon, Patrick Michael, Park, Andrew J., Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph Rudolph, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase I study to evaluate the safety and tolerability of MEDI4736, an anti- programmed cell death-ligand-1 (PD-L1) antibody, in combination with tremelimumab in patients with advanced solid tumors
Ott, Patrick Alexander, Callahan, Margaret K., Odunsi, Kunle, Park, Andrew J., Pan, Linda S., Venhaus, Ralph Rudolph, Karakunnel, Joyson Joseph, Hodi, F. Stephen, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM)
Reardon, David A., Kaley, Thomas Joseph, Dietrich, Jorg, Lim, Michael, Dunn, Gavin P, Gan, Hui Kong, Cloughesy, Timothy Francis, Clarke, Jennifer Leigh, Park, Andrew J., Macri, Mary J., Ryan, Aileen, Ricciardi, Toni, Reddy, Vijay, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase 1 study to evaluate the safety and tolerability of MEDI4736, an anti–PD-L1 antibody, in combination with tremelimumab in patients with advanced solid tumors
Callahan, Margaret K., Ott, Patrick Alexander, Odunsi, Kunle, Bertolini, Stephane V., Pan, Linda S., Venhaus, Ralph Rudolph, Karakunnel, Joyson Joseph, Hodi, F. Stephen, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase I/II study of the TLR3 agonist poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 vg in patients with melanoma
Sabado, Rachel Lubong, Pavlick, Anna C., Gnjatic, Sacha, Ott, Patrick Alexander, Hasan, Farah, Spadaccia, Meredith, Vengco, Isabelita, Holman, Rose Marie, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Stein, Claire, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Bhardwaj, Nina
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase II study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM)
Reardon, David A., Dietrich, Jorg, Kaley, Thomas Joseph, Gan, Hui Kong, Dunn, Gavin P, Cloughesy, Timothy Francis, Lim, Michael, Clarke, Jennifer Leigh, Park, Andrew J., Pan, Linda S., Lai, Dominic W, Karakunnel, Joyson Joseph, Robbins, Paul B., Narwal, Rajesh, Venhaus, Ralph Rudolph
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article